Cellosaurus MDA-MB-231 NAT1+/- 2-12 (CVCL_A9BD)
Cell line name | MDA-MB-231 NAT1+/- 2-12 |
---|---|
Synonyms | CRISPR 2-12 |
Accession | CVCL_A9BD |
Resource Identification Initiative | To cite this cell line use: MDA-MB-231 NAT1+/- 2-12 (RRID:CVCL_A9BD) |
Comments | Group: Triple negative breast cancer (TNBC) cell line. Population: Caucasian. Characteristics: Transfected with a scrambled NAT1 shRNA. Knockout cell: Method=CRISPR/Cas9; HGNC; 7645; NAT1 (Note=1 of 2 alleles). Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
Sequence variations |
|
Disease | Breast adenocarcinoma (NCIt: C5214) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_A9BA (MDA-MB-231 NAT1 scrambled) |
Sex of cell | Female |
Age at sampling | 51Y |
Category | Cancer cell line |
Publications | PubMed=32555504; DOI=10.1038/s41598-020-66863-4; PMCID=PMC7299936 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_A9BD |
Encyclopedic resources | Wikidata; Q108820876 |
Entry history | |
Entry creation | 23-Sep-2021 |
Last entry update | 30-Jan-2024 |
Version number | 7 |